The EU pharmaceutical landscape is undergoing its most significant transformation in more than 20 years. The EU Pharma Package, the Biotech Act, the Joint Clinical Assessment Regulation (JCA/HTA), the AI Act and ongoing discussions on the Critical Medicines Regulation are creating unprecedented regulatory momentum across the sector.
Join us to explore the latest developments, discuss their implications for industry and healthcare stakeholders, and connect with experts and decision-makers from across the pharmaceutical ecosystem.
Further details on the programme and speakers will be announced soon.
Secure your spot now. We look forward to seeing you!
In Person
